Bryan Young

Bryan leads ARC’s preclinical program, which passed more than a dozen different biocompatibility tests following the ISO 10993 set of biocompatibility standards, and Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has initiated, controlled, and closed in vivo preclinical research projects, including study protocol design, study monitoring, and writing of scientific study reports.

Bryan spent more than 6 years in polysaccharide research and with the ARC Team developed projects on fucoidan extraction, purification, structural modification, and characterization resulting in a substantial contribution to ARC’s patent portfolio. Bryan was a key figure in manufacturing activities that included the successful transfer of ARC’s bench-scale experiments to a pilot-scale production process that made batches of ARC’s adhesion barrier product for use in preclinical research and Phase I clinical trials, following ISO 13485:2016 compliance requirements for manufacturing medical devices.

Bryan has a BSc in Biochemistry and a certificate for Advanced Project Management.